InvestSMART

Pro Medicus Limited (ASX: PME) - Announcements

Current share price for PME : $178.860 4.85 (2.64%)+

ASX company news and announcements for Pro Medicus Limited (PME) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Pro Medicus Limited (PME) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Pro Medicus Limited (PME), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Pro Medicus Limited (PME)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$18,685 Notification of cessation of securities - PME 26 Aug 2024 11:24AM $149.230 $178.860 risen by 19.86%
$18,685 Application for quotation of securities - PME 26 Aug 2024 11:01AM $148.000 $178.860 risen by 20.85%
$18,685 PME FY2024 results presentation 14 Aug 2024 11:01AM $139.520 $178.860 risen by 28.20%
$18,685 CEO Interview - FY results 14 Aug 2024 9:21AM $131.590 $178.860 risen by 35.92%
$18,685 Dividend/Distribution - PME 14 Aug 2024 9:04AM $131.590 $178.860 risen by 35.92%
$18,685 2024 Corporate Governance Statement 14 Aug 2024 9:01AM $131.590 $178.860 risen by 35.92%
$18,685 Appendix 4G 14 Aug 2024 9:00AM $131.590 $178.860 risen by 35.92%
$18,685 Annual Report 2024 14 Aug 2024 9:00AM $131.590 $178.860 risen by 35.92%
$18,685 PME Full Year Results 14 Aug 2024 8:57AM $131.590 $178.860 risen by 35.92%
$18,685 Preliminary Final Report 14 Aug 2024 8:56AM $131.590 $178.860 risen by 35.92%
$18,685 PME FY24 Results release date and webcast briefing 12 Jul 2024 8:34AM $134.240 $178.860 risen by 33.24%
$18,685 PME signs five new deals with a combined minimum of A$45M 28 May 2024 9:29AM $113.240 $178.860 risen by 57.95%
$18,685 Macquarie Conference May 2024 Presentation 8 May 2024 9:26AM $113.100 $178.860 risen by 58.14%
$18,685 Notification of buy-back - PME 2 Apr 2024 8:35AM $103.750 $178.860 risen by 72.40%
$18,685 Update - Notification of buy-back - PME 2 Apr 2024 8:33AM $103.750 $178.860 risen by 72.40%
$18,685 S&P DJI Announces March 2024 Quarterly Rebalance 1 Mar 2024 5:03PM $103.390 $178.860 risen by 73%
$18,685 Notification of cessation of securities - PME 27 Feb 2024 3:46PM $100.830 $178.860 risen by 77.39%
$18,685 Notification of cessation of securities - PME 27 Feb 2024 3:45PM $100.830 $178.860 risen by 77.39%
$18,685 Notification of cessation of securities - PME 27 Feb 2024 3:44PM $100.830 $178.860 risen by 77.39%
$18,685 Update - Notification of buy-back - PME 26 Feb 2024 8:08AM $98.220 $178.860 risen by 82.10%
$18,685 Update - Notification of buy-back - PME 23 Feb 2024 8:07AM $94.530 $178.860 risen by 89.21%
$18,685 Update - Notification of buy-back - PME 22 Feb 2024 8:09AM $92.990 $178.860 risen by 92.34%
$18,685 Change of Director's Interest Notice - Alice Williams 21 Feb 2024 8:15AM $94.830 $178.860 risen by 88.61%
$18,685 Notification of cessation of securities - PME 21 Feb 2024 8:11AM $94.830 $178.860 risen by 88.61%
$18,685 Notification of cessation of securities - PME 21 Feb 2024 8:10AM $94.830 $178.860 risen by 88.61%

151 - 175 of 669 results

Page 7 of 27

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.